
Novaestiq Announces Positive Data from Pivotal Trial for saypha® MagIQ™ Injectable Hyaluronic Acid (HA) Gel
saypha MagIQ is currently in the FDA approval process SOUTHLAKE, TX, UNITED STATES, May 16, 2025 /EINPresswire.com/ -- • saypha® MagIQ™ met the primary and key secondary endpoints of non-inferiority to Juvéderm® Ultra XC at 24 weeks, with slightly …